Through inhibiting Aβ1-42 formation and histone deacetylase 2 (HDAC2) expression, leading to downregulation of glucocorticoid receptor 1 activity, L1 can alleviate AD pathology [22]. This evidence concerns the gene HDAC2 and Alzheimer disease.